Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Arthritis, Juvenile | 11 | 2019 | 191 | 4.15 | Why? |
| Uveitis | 8 | 2018 | 233 | 2.70 | Why? |
| Adalimumab | 4 | 2019 | 389 | 1.74 | Why? |
| Osteomyelitis | 3 | 2018 | 131 | 1.42 | Why? |
| Macrophage Activation Syndrome | 4 | 2021 | 342 | 1.00 | Why? |
| Systemic Inflammatory Response Syndrome | 5 | 2021 | 6653 | 0.86 | Why? |
| Osteitis | 1 | 2018 | 6 | 0.78 | Why? |
| Antirheumatic Agents | 6 | 2019 | 3023 | 0.76 | Why? |
| Sacroiliitis | 1 | 2018 | 24 | 0.75 | Why? |
| Scurvy | 1 | 2017 | 10 | 0.72 | Why? |
| Churg-Strauss Syndrome | 1 | 2017 | 61 | 0.64 | Why? |
| Methotrexate | 2 | 2018 | 471 | 0.63 | Why? |
| Biosimilar Pharmaceuticals | 1 | 2019 | 205 | 0.63 | Why? |
| Drug Substitution | 1 | 2019 | 385 | 0.61 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 317 | 0.61 | Why? |
| Biological Therapy | 2 | 2018 | 456 | 0.58 | Why? |
| Granulomatosis with Polyangiitis | 1 | 2017 | 161 | 0.55 | Why? |
| Antibodies, Monoclonal, Humanized | 6 | 2021 | 9335 | 0.51 | Why? |
| Receptors, Interleukin-6 | 1 | 2021 | 1383 | 0.49 | Why? |
| Pericardial Effusion | 1 | 2017 | 312 | 0.48 | Why? |
| Immunoglobulins, Intravenous | 2 | 2020 | 2705 | 0.44 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 800 | 0.41 | Why? |
| Child | 23 | 2021 | 70012 | 0.39 | Why? |
| Patients | 1 | 2017 | 1167 | 0.39 | Why? |
| Immunologic Factors | 2 | 2021 | 4206 | 0.33 | Why? |
| Autoimmune Diseases | 1 | 2018 | 1996 | 0.27 | Why? |
| Child, Preschool | 10 | 2021 | 36283 | 0.25 | Why? |
| Rheumatic Diseases | 1 | 2019 | 2675 | 0.24 | Why? |
| Immunosuppressive Agents | 3 | 2017 | 6331 | 0.23 | Why? |
| Lymphadenitis | 1 | 2021 | 53 | 0.22 | Why? |
| Stomatitis, Aphthous | 1 | 2021 | 43 | 0.22 | Why? |
| Adolescent | 12 | 2020 | 86841 | 0.21 | Why? |
| Glucocorticoids | 5 | 2021 | 4431 | 0.21 | Why? |
| Heart Diseases | 1 | 2017 | 3503 | 0.20 | Why? |
| Quality of Life | 2 | 2018 | 9820 | 0.19 | Why? |
| Immunity, Innate | 1 | 2018 | 6570 | 0.19 | Why? |
| India | 3 | 2021 | 11875 | 0.19 | Why? |
| International Normalized Ratio | 1 | 2020 | 300 | 0.18 | Why? |
| Prothrombin Time | 1 | 2020 | 434 | 0.18 | Why? |
| Age of Onset | 2 | 2017 | 557 | 0.18 | Why? |
| Infant | 5 | 2021 | 30274 | 0.18 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.17 | Why? |
| Synovitis | 1 | 2017 | 47 | 0.17 | Why? |
| Whole Body Imaging | 1 | 2018 | 116 | 0.17 | Why? |
| Diphosphonates | 1 | 2018 | 121 | 0.17 | Why? |
| Child, Hospitalized | 1 | 2021 | 556 | 0.16 | Why? |
| Pharyngitis | 1 | 2021 | 687 | 0.16 | Why? |
| Bone and Bones | 1 | 2018 | 235 | 0.16 | Why? |
| Knee Joint | 1 | 2017 | 194 | 0.15 | Why? |
| Bone Density Conservation Agents | 1 | 2018 | 209 | 0.15 | Why? |
| Purines | 1 | 2021 | 816 | 0.15 | Why? |
| Gene-Environment Interaction | 1 | 2016 | 127 | 0.15 | Why? |
| Intention to Treat Analysis | 1 | 2017 | 673 | 0.15 | Why? |
| Azetidines | 1 | 2021 | 722 | 0.15 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.14 | Why? |
| Vision Disorders | 1 | 2018 | 260 | 0.14 | Why? |
| Humans | 30 | 2021 | 930598 | 0.14 | Why? |
| Female | 17 | 2021 | 380317 | 0.13 | Why? |
| Fever | 2 | 2021 | 7795 | 0.13 | Why? |
| Male | 16 | 2021 | 367725 | 0.13 | Why? |
| Arthritis | 1 | 2017 | 288 | 0.13 | Why? |
| Treatment Failure | 1 | 2019 | 2106 | 0.13 | Why? |
| Intensive Care Units, Pediatric | 1 | 2020 | 1098 | 0.13 | Why? |
| Biological Products | 2 | 2018 | 2331 | 0.12 | Why? |
| Drug Monitoring | 1 | 2021 | 1408 | 0.12 | Why? |
| Double-Blind Method | 3 | 2021 | 5988 | 0.12 | Why? |
| Sulfonamides | 1 | 2021 | 1294 | 0.12 | Why? |
| Phenotype | 2 | 2021 | 4037 | 0.12 | Why? |
| Aspirin | 1 | 2020 | 1043 | 0.12 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.11 | Why? |
| Bronchodilator Agents | 1 | 2017 | 444 | 0.11 | Why? |
| Patient Reported Outcome Measures | 1 | 2017 | 912 | 0.11 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.11 | Why? |
| Pyrazoles | 1 | 2021 | 1791 | 0.11 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.11 | Why? |
| Pleural Effusion | 1 | 2017 | 680 | 0.11 | Why? |
| Child Health | 1 | 2020 | 940 | 0.10 | Why? |
| Interviews as Topic | 1 | 2019 | 1952 | 0.10 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.10 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2020 | 1671 | 0.10 | Why? |
| Autism Spectrum Disorder | 1 | 2017 | 587 | 0.10 | Why? |
| Macrophages | 1 | 2021 | 2784 | 0.09 | Why? |
| Autoimmunity | 1 | 2016 | 841 | 0.09 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.09 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.09 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 1645 | 0.09 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.09 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.08 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.08 | Why? |
| Drug Therapy, Combination | 2 | 2021 | 7268 | 0.08 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.08 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.08 | Why? |
| Early Diagnosis | 1 | 2016 | 2443 | 0.08 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.08 | Why? |
| C-Reactive Protein | 2 | 2020 | 7972 | 0.08 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.08 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.07 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.07 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.06 | Why? |
| Psoriasis | 1 | 2017 | 1739 | 0.06 | Why? |
| Parents | 1 | 2017 | 2758 | 0.06 | Why? |
| Asymptomatic Diseases | 1 | 2016 | 3444 | 0.06 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.06 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
| Caregivers | 1 | 2018 | 3112 | 0.06 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| United Kingdom | 2 | 2020 | 18046 | 0.06 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.05 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.05 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.05 | Why? |
| Tomography, X-Ray Computed | 2 | 2017 | 25144 | 0.05 | Why? |
| Retrospective Studies | 4 | 2018 | 105322 | 0.05 | Why? |
| South America | 1 | 2021 | 565 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.05 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.05 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.05 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.05 | Why? |
| Choroiditis | 1 | 2017 | 18 | 0.04 | Why? |
| Mice | 1 | 2018 | 21357 | 0.04 | Why? |
| Presenteeism | 1 | 2018 | 63 | 0.04 | Why? |
| England | 2 | 2021 | 5116 | 0.04 | Why? |
| Europe | 3 | 2021 | 12702 | 0.04 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.04 | Why? |
| North America | 1 | 2021 | 1400 | 0.04 | Why? |
| Joints | 1 | 2017 | 97 | 0.04 | Why? |
| Syndrome | 1 | 2021 | 1310 | 0.04 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.04 | Why? |
| Absenteeism | 1 | 2018 | 287 | 0.04 | Why? |
| Mass Screening | 1 | 2016 | 8005 | 0.04 | Why? |
| Cross-Sectional Studies | 3 | 2018 | 53120 | 0.04 | Why? |
| Blood Sedimentation | 1 | 2017 | 508 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.04 | Why? |
| Efficiency | 1 | 2018 | 420 | 0.03 | Why? |
| Drug Costs | 1 | 2018 | 313 | 0.03 | Why? |
| Remission Induction | 1 | 2018 | 950 | 0.03 | Why? |
| Asia | 1 | 2021 | 2399 | 0.03 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.03 | Why? |
| Adult | 4 | 2021 | 244371 | 0.03 | Why? |
| Sarcoidosis | 1 | 2017 | 271 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2020 | 1425 | 0.03 | Why? |
| Delphi Technique | 1 | 2016 | 1257 | 0.03 | Why? |
| Visual Acuity | 1 | 2017 | 790 | 0.03 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.03 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.03 | Why? |
| Health Expenditures | 1 | 2018 | 904 | 0.03 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.02 | Why? |
| Animals | 1 | 2018 | 78931 | 0.02 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.02 | Why? |
| Exanthema | 1 | 2017 | 1097 | 0.02 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.02 | Why? |
| Health Surveys | 1 | 2018 | 2841 | 0.02 | Why? |
| Employment | 1 | 2018 | 1754 | 0.02 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.02 | Why? |
| United States | 3 | 2018 | 46150 | 0.02 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.02 | Why? |
| Rheumatology | 1 | 2016 | 1213 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2017 | 1962 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Canada | 1 | 2017 | 6018 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.01 | Why? |
| Logistic Models | 1 | 2016 | 9089 | 0.01 | Why? |
| Societies, Medical | 1 | 2016 | 6907 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Risk Factors | 2 | 2018 | 71621 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |
| Aged | 1 | 2021 | 215776 | 0.00 | Why? |
Ramanan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(212)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_